Our identified relationship between high levels of PMCA2 mRNA and patient survival in basal breast cancers, may represent an ability for PMCA2 to identify less aggressive basal breast cancers and signify that PMCA2 overexpression is a not a driver in breast cancer. This evidence concerns the gene ATP2B2 and breast cancer.